Efficacy of Three Dimensional Transesophageal Echocardiography for Percutaneous Device Closure in Atrial Septal Defect
Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18-80
SponsorAsan Medical Center
About this trial
Background: Three-dimensional echocardiographic image for atrial septal defect (ASD) is useful for evaluation of defect size and shape. The investigators suggested optimal device size using three-dimensional transesophageal echocardiographic image and our formula in previous study.
Purpose: In this study, the investigators seek to predict the correct device size and confirm the accuracy of the formula that we made before device closure in ASD patients.
Eligibility criteria
Qualifiers
Age ≥18 year-old
Susceptible indication for atrial septal defect closure
Potential candidate for device closure
Disqualifiers
Poor candidate for device closure: multiple ASDs, ect
Other heart disease requiring open heart surgery
Trial design
Treatments tested in this trial
- Transcatheter device closure
Treatment groups
100 Participants
are divided into 1 treatment groupSponsors and collaborators
Source ClinicalTrials.gov